Thermal proteome profiling of breast cancer cells reveals proteasomal activation by CDK4/6 inhibitor palbociclib.
about
Anti-cancer therapy: senescence is the new black.Proteomic analysis identifies highly expressed plasma membrane proteins for detection and therapeutic targeting of specific breast cancer subtypesThe HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction
P2860
Thermal proteome profiling of breast cancer cells reveals proteasomal activation by CDK4/6 inhibitor palbociclib.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Thermal proteome profiling of ...... CDK4/6 inhibitor palbociclib.
@en
Thermal proteome profiling of ...... CDK4/6 inhibitor palbociclib.
@nl
type
label
Thermal proteome profiling of ...... CDK4/6 inhibitor palbociclib.
@en
Thermal proteome profiling of ...... CDK4/6 inhibitor palbociclib.
@nl
prefLabel
Thermal proteome profiling of ...... CDK4/6 inhibitor palbociclib.
@en
Thermal proteome profiling of ...... CDK4/6 inhibitor palbociclib.
@nl
P2093
P2860
P356
P1433
P1476
Thermal proteome profiling of ...... CDK4/6 inhibitor palbociclib.
@en
P2093
Anetta Härtlova
Julien Peltier
Marek Gierliński
Mikael Björklund
Valerie M Jansen
P2860
P356
10.15252/EMBJ.201798359
P407
P577
2018-04-18T00:00:00Z